Hepatitis B (HBV): HBeAg

Hepatitis B (HBV) is one of the most common and serious liver infections in the world. This virus can lead to chronic liver disease, cirrhosis, and even liver cancer. For effective treatment and monitoring of the disease, it is important to study various aspects of HBV, including HBeAg and the infection panel.

Hepatitis B is a viral infection that is transmitted through contact with the blood, urine, saliva, or genital secretions of an infected person. The main routes of HBV transmission are unprotected sex, sharing sterile syringes, blood transfusion, and from mother to child during childbirth. One of the key aspects of monitoring hepatitis B is determining the presence of HBeAg and other parameters of the infection panel.

HBeAg, or “Hepatitis B e Antigen”, is a protein produced by the HBV virus during active replication in the human body. The presence of HBeAg in the blood indicates high viral replication and a high risk of transmission to others. The main function of HBeAg is to facilitate transmission of the virus through blood and other secretions.

The hepatitis B infection panel also includes other important parameters, such as:

1. HBsAg (hepatitis B surface antigen): This antigen indicates the presence of HBV virus in the blood. If HBsAg is detected in the blood for more than 6 months, it may indicate chronic hepatitis B infection.
2. Anti-HBs (antibodies to hepatitis B surface antigen): These antibodies are produced after vaccination or as a result of previous recovery from hepatitis B. Their presence indicates immunity to the virus.
3. Anti-HBc (antibodies to hepatitis B core antigen): These antibodies may be positive in cases of active or past HBV infection.
4. HBV DNA (hepatitis B viral load): This test determines the number of copies of the HBV virus in the blood, which is useful for assessing the activity of the infection and choosing the optimal treatment.

Monitoring the infection panel is an important part of the diagnosis, treatment, and surveillance of hepatitis B. It allows doctors to determine the stage and activity of the infection, choose the optimal treatment method, and monitor the results of therapy. It is also important to provide information to patients about prevention and vaccination to prevent the spread of hepatitis B.

In conclusion, hepatitis B is a serious infection that can lead to severe complications. Monitoring the infection panel, in particular the determination of HBeAg, helps to detect and control the infection in time to prevent further complications and spread of the virus. Prevention and vaccination are effective means of protection against hepatitis B and its consequences.